Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rotmensch

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Heart & Lung : the Journal of Critical Care|July 1, 1984
Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarctionH H Rotmensch, P H Vlasses, R K Ferguson
Comprehensive Therapy|November 1, 1982
Common pitfalls in the treatment of hypertensionH H Rotmensch, P H Vlasses, R K Ferguson
Pharmacotherapy|March 1, 1983
Resolution of captopril-induced rash after substitution of enalaprilH H Rotmensch, P H Vlasses, R K Ferguson
Antimicrobial Agents and Chemotherapy|March 1, 1992
Distribution of ciprofloxacin in ascitic fluid following administration of a single oral dose of 750 milligramsM Dan, T Zuabi, C Quassem, et al.
Drug Intelligence & Clinical Pharmacy|July 1, 1985
The role of beta-blocking agents following myocardial infarctionP H Vlasses, H H Rotmensch, R K Ferguson
The Medical Clinics of North America|March 1, 1988
Angiotensin-converting enzyme inhibitorsH H Rotmensch, P H Vlasses, R K Ferguson
Harefuah|June 15, 1977
[Myocardial infarction during thyroxin therapy]H H Rotmensch, L Laurian, J B Lessing, et al.
Archives of Internal Medicine|September 1, 1980
Mitral valve prolapse in identical twinsH H Rotmensch, O Ayzenberg, J J Jacobi, et al.
Journal of Human Hypertension|September 1, 1996
Prescribing pattern of antihypertensive drugs in the communityH H Rotmensch, L Mendelevitch, D S Silverberg, et al.
Nephron. Clinical Practice|April 26, 2005
Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal diseaseGideon Charach, Itamar Grosskopf, Heschi H Rotmensch, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Heart & Lung : the Journal of Critical Care|July 1, 1984
Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarctionH H Rotmensch, P H Vlasses, R K Ferguson
Comprehensive Therapy|November 1, 1982
Common pitfalls in the treatment of hypertensionH H Rotmensch, P H Vlasses, R K Ferguson
Pharmacotherapy|March 1, 1983
Resolution of captopril-induced rash after substitution of enalaprilH H Rotmensch, P H Vlasses, R K Ferguson
Antimicrobial Agents and Chemotherapy|March 1, 1992
Distribution of ciprofloxacin in ascitic fluid following administration of a single oral dose of 750 milligramsM Dan, T Zuabi, C Quassem, et al.
Drug Intelligence & Clinical Pharmacy|July 1, 1985
The role of beta-blocking agents following myocardial infarctionP H Vlasses, H H Rotmensch, R K Ferguson
The Medical Clinics of North America|March 1, 1988
Angiotensin-converting enzyme inhibitorsH H Rotmensch, P H Vlasses, R K Ferguson
Harefuah|June 15, 1977
[Myocardial infarction during thyroxin therapy]H H Rotmensch, L Laurian, J B Lessing, et al.
Archives of Internal Medicine|September 1, 1980
Mitral valve prolapse in identical twinsH H Rotmensch, O Ayzenberg, J J Jacobi, et al.
Journal of Human Hypertension|September 1, 1996
Prescribing pattern of antihypertensive drugs in the communityH H Rotmensch, L Mendelevitch, D S Silverberg, et al.
Nephron. Clinical Practice|April 26, 2005
Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal diseaseGideon Charach, Itamar Grosskopf, Heschi H Rotmensch, et al.
Pageof 9